Because depression in brain cancer patients is a common but often overlooked condition, oncologists should regularly screen tumor patients for depression, according to a new article. The authors also propose that more studies be completed to explore the efficacy of anti-depression treatments, as well as the value of depression biomarkers for future brain tumor research.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1QJDXYO
No comments:
Post a Comment